Antifungal drugs in pregnancy: a review

Expert Opinion on Drug Safety - Tập 2 Số 5 - Trang 475-483 - 2003
Varsha Moudgal1, Jack D. Sobel2
1Division of Infectious Diseases, Harper Hospital, 3990 John R, 4 Brush Center, Detroit, MI 48201, USA.
2Professor and Chief, Division of Infectious Diseases, Harper Hospital, 3990 John R, 4 Brush Center, Detroit, MI 48201, USA. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.2165/00002018-200023010-00005

10.1093/clinids/7.3.287

10.2165/00003088-198005040-00003

10.2165/00003088-197702030-00002

FORFAR JO, 1973, Chi]. Pharmacol Ther., 14, 632, 10.1002/cpt1973144part2632

10.1097/00000542-197508000-00004

10.1016/S0002-9378(85)80003-X

10.1378/chest.86.3_Supplement.14S

RODRIGUES J, 1992, CBI]. Chest Med., 13, 679, 10.1016/S0272-5231(21)01135-7

10.3109/00016348009160086

10.1111/j.1471-0528.1973.tb02195.x

COTCH MF, 1998, Vaginal infections and prematurity study group. Am. J Obstet. Gyrrecol, 178, 374

MAZOR M, 1993, Implications for obstetric and neonatal management. Acta Obstet. Gyrrecol. Scam/., 72, 52

10.1016/0028-2243(91)90298-Y

10.1016/S0002-9378(94)70140-7

10.1086/514977

10.1038/244292a0

10.1016/S0140-6736(87)92015-0

10.1016/S0140-6736(87)91533-9

DIFLUCAN PACKAGE INSERT: New York., 2003, Roerig Division, Pfizer

10.1097/00006454-199202000-00012

10.1093/clinids/22.2.336

10.1002/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO;2-S

10.1016/S0002-9378(96)70119-9

10.1592/phco.19.3.221.30919

DAVIS JE, 1974, Obstet. Cyrrecol, 44, 403

MCNELLIS D, 1977, A comparative study. Obstet. Cyrrecol, 50, 674

ABRAMS LS, 1983, Am. 1. Obstet. Cyrrecol, 147, 970, 10.1016/0002-9378(83)90257-0

ROSA FW, 1987, Obstet. Cyrrecol, 69, 751

10.1016/S0002-9378(85)80006-5

FRERICH W, 1977, Cum: Med. Res. Opirr., 4, 640

10.3109/00016347809156527

NO AUTHORS LISTED, 2002, Centers for Disease Control and Prevention. MMWR Recomm. Rep., 51, 1

10.1016/S0002-9378(98)80001-X

10.1001/archinte.1972.03650060100018

VANDERVEEN EE, 1982, Cutts, 30, 761

10.1016/0002-9343(69)90245-9

10.1016/S0140-6736(70)91736-8

10.1097/00006254-198305000-00001

10.1128/AAC.14.6.903

PHILPOT CR, 1972, Med. J. Aust., 2, 1005, 10.5694/j.1326-5377.1972.tb103682.x

10.1136/bmj.4.5888.337

CUROLE DN, 1981, 1 Reprod. Med., 26, 317

10.1056/NEJM198709243171307

10.2165/00003495-198223010-00001

10.1016/0002-9378(84)90693-8

10.1136/pgmj.66.773.221

TIBONI GM, 1993, Res. Commun. Chem. Raffia. Pharmacol., 79, 381

10.1093/clinids/18.3.364

10.1097/00006454-198701000-00024

ISMAIL MA, 1982, Am. Rev Respir. Dis., 126, 350

HOBERMAN AM FJ, MARTIN, 1994, T etal.: Developmental toxicity studies of amphocil (tm) administered intravenously to Sprague-Dawley rats and new zealand white rabbits. Toxicologist, 14, 160

10.1086/313749

ABELCET PACKAGE INSERT: Princeton, NJ., 2003, The Liposome Company

AMPHOTEC PACKAGE INSERT: Menlo Park, CA., 2003, Sequus Pharmaceuticals

10.3109/00365549409011824

10.1128/AAC.44.2.368-377.2000

10.1093/jac/dkf045

10.1128/AAC.46.9.3001-3012.2002